Real-time enrollment status for this cll/sll clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:27 AM UTC
| NCT Number | NCT04215809 |
| Recruiting Status | Recruiting |
| Condition | CLL/SLL |
| Phase | Clinical Trial |
| Target Enrollment | 144 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Ascentage Pharma Group Inc. |
| Last Updated on CT.gov | April 10, 2025 (Apr 10, 2025) |
As of July 13, 2026: Clinical trial NCT04215809 is currently recruiting participants. This clinical trial study for cll/sll is actively seeking new participants at 7 locations across the United States. The study is sponsored by Ascentage Pharma Group Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04215809 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04215809 was last updated Apr 10, 2025 (April 10, 2025). HelloStudys verifies this status automatically.